A randomized in vitro investigation on the modulation of the TGF-β signaling pathway and induction of apoptosis in colorectal cancer cells by green seaweed Caulerpa racemosa

Colorectal cancer (CRC) poses a significant global health burden, necessitating innovative treatment strategies. This study evaluates the potential of Caulerpa racemosa extract, a natural compound, to modulate the transforming growth factor-beta (TGF-β) signaling pathway and induce apoptosis in CRC...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of agriculture and food research 2023-12, Vol.14, p.100796, Article 100796
Hauptverfasser: Permatasari, Happy Kurnia, Bdira, Sarra Ben, Moon, Myunghan, Amalia, Nurlinah, Sulistomo, Hikmawan Wahyu, Riawan, Wibi, Choi, Jinwon, Chung, Sanghyun, Park, Moon Nyeo, Seo, Byung-Kwan, Nurkolis, Fahrul, Kim, Bonglee
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Colorectal cancer (CRC) poses a significant global health burden, necessitating innovative treatment strategies. This study evaluates the potential of Caulerpa racemosa extract, a natural compound, to modulate the transforming growth factor-beta (TGF-β) signaling pathway and induce apoptosis in CRC cells. HT-29 cells served as an in vitro CRC model. The cells were exposed to an n-hexane extract of C. racemosa, and TGF-β1 expression was assessed using immunofluorescence. Apoptosis was quantified via annexin V and propidium iodide staining through flow cytometry. C. racemosa extract significantly downregulated TGF-β1 expression compared to the control group, suggesting its potential as a CRC tumorigenesis and progression inhibitor. The extract displayed robust pro-apoptotic activity, with the 800 μg/mL dose significantly increasing early apoptotic cells compared to the 1200 μg/mL dose. Other dose comparisons showed no significant differences, indicating an optimal dosage range for early apoptosis induction at 800 μg/mL. The 1200 μg/mL dose also induced a notable increase in necrotic/late apoptotic cells compared to the control, triggering a more potent apoptotic response in advanced stages. Our study highlights the potential of C. racemosa extract to modulate the TGF-β signaling pathway and induce apoptosis in CRC cells. The observed dose-dependent effects on early and late apoptotic cells suggest potential applications as a preventive or therapeutic agent in CRC treatment. Further investigations are warranted to explore the extract's role in combatting CRC's complex pathogenesis. [Display omitted] •Green seaweed Caulerpa racemosa extract significantly downregulated TGF-β1 expression.•The extract C. racemosa displayed robust pro-apoptotic activity.•C. racemosa potentially as a CRC tumorigenesis and progression inhibitor.•C. racemosa extract modulate the TGF-β signaling pathway and induce apoptosis in CRC cells.
ISSN:2666-1543
2666-1543
DOI:10.1016/j.jafr.2023.100796